SCHEMBL1822246

SCHEMBL1822246

CN1CC2(CCNCC2)c2ccc(Br)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 2/20 0.42
SIGMAR1 Q99720 2/20 0.42
BRD4 O60885 1/20 0.36
HTR2C P28335 3/20 0.35
AKT1 P31749 2/20 0.34
PNMT P11086 1/20 0.33
NOTUM Q6P988 1/20 0.33
ASIC3 Q9UHC3 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HTR2A P28223 2/20 0.33
HTR2B P41595 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1820468 0.91 SLC18A3 (0.38) SLC18A3SIGMAR1BRD4HTR2CPNMT
SCHEMBL1823222 0.91 SLC18A3 (0.38) SLC18A3SIGMAR1BRD4HTR2CPNMT
SCHEMBL17771735 0.88 SIGMAR1 (0.42) SLC18A3SIGMAR1BRD4HTR2CAKT1
SCHEMBL31330397 0.85 SLC18A3 (0.41) SLC18A3SIGMAR1BRD4HTR2CNOTUM
SCHEMBL22479310 0.83 SLC18A3 (0.45) SLC18A3SIGMAR1BRD4HTR2CAKT1
SCHEMBL23558662 0.81 AKT1 (0.43) SLC18A3SIGMAR1HTR2CAKT1NOTUM
SCHEMBL30232512 0.81 AKT1 (0.43) SLC18A3SIGMAR1HTR2CAKT1NOTUM
SCHEMBL22471588 0.81 PIK3CA (0.45) SLC18A3SIGMAR1BRD4HTR2CAKT1
Hydrochloric Acid SCHEMBL29931855 0.80 AKT1 (0.42) SLC18A3SIGMAR1HTR2CAKT1NOTUM
SCHEMBL17771723 0.78 AKT1 (0.37) SLC18A3SIGMAR1HTR2CAKT1NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113330008-B Preparation method of amide compound and application of amide compound in medicine field 上海华汇拓医药科技有限公司 2024-05-07 CN disclosed
EP-3950682-A1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD Shanghai Synergy Pharmaceutical Sciences Co., Ltd (CN) 2022-02-09 EP disclosed
CN-113330008-A Preparation method of amide compound and application of amide compound in field of medicine 上海华汇拓医药科技有限公司 2021-08-31 CN disclosed
WO-2020192652-A1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD 上海华汇拓医药科技有限公司 2020-10-01 WO disclosed
WO-2020192652-A1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD 上海华汇拓医药科技有限公司 2020-10-01 WO disclosed
EP-2315751-A1 ALKYNYL ALCOHOLS AS KINASE INHIBITORS Amgen Inc. (US) 2011-05-04 EP disclosed
WO-2009158011-A1 ALKYNYL ALCOHOLS AS KINASE INHIBITORS AMGEN INC. (US) 2009-12-30 WO disclosed